đ Alibaba Group Downgraded, Cleveland-Cliffs Downgraded, ZoomInfo Technologies Downgraded and moreâŠ
RJ Hamster
Ratings changes for ARM, Tempest Therapeutics, Fortinet, AstraZeneca, PayPal, ZoomInfo Technologies, GoPro and moreâŠUpgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
Multimillionaire Trader Nate Bear just keeps winning: thanks to his One Ticker Payouts strategy that he revealed back in August, heâs put up a 52% total returnâŠWhich has beat the marketâs performance by nearly 9x! You can get access to this weekâs tradeâŠ
Apple Inc. (NASDAQ:AAPL) declared a quarterly dividend on Thursday, February 1st. Investors of record on Monday, February 12th will be given a dividend of 0.24 per share by the iPhone maker on Thursday, February 15th. This represents a $0.96 annualized dividend and a dividend yield of 0.51%. The ex-dividend date is Friday, February 9th.
CEO Mark Zuckerberg sold 34,398 shares of the firmâs stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $457.52, for a total transaction of $15,737,772.96. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
insider Jennifer Newstead sold 552 shares of Meta Platforms stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $464.00, for a total value of $256,128.00. Following the completion of the transaction, the insider now owns 34,168 shares of the companyâs stock, valued at $15,853,952. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Meta Platforms saw some unusual options trading on Wednesday. Stock investors bought 515,526 call options on the stock. This is an increase of 32% compared to the average volume of 389,579 call options.
Ally Financial (NYSE:ALLY) was upgraded by analysts at Morgan Stanley from an âequal weightâ rating to an âoverweightâ rating. They now have a $47.00 price target on the stock, up previously from $37.00. This represents a 31.5% upside from the current price of $35.75.
Criteo (NASDAQ:CRTO) was upgraded by analysts at Wells Fargo & Company from an âequal weightâ rating to an âoverweightâ rating. They now have a $41.00 price target on the stock, up previously from $28.00. This represents a 28.6% upside from the current price of $31.89.
Discover Financial Services (NYSE:DFS) was upgraded by analysts at Morgan Stanley from an âequal weightâ rating to an âoverweightâ rating. They now have a $133.00 price target on the stock, up previously from $105.00. This represents a 23.4% upside from the current price of $107.80.
Walt Disney (NYSE:DIS) was upgraded by analysts at Needham & Company LLC from a âholdâ rating to a âbuyâ rating. They now have a $120.00 price target on the stock. This represents a 7.0% upside from the current price of $112.18.
Edgewell Personal Care (NYSE:EPC) was upgraded by analysts at Barclays PLC from an âunderweightâ rating to an âequal weightâ rating. They now have a $39.00 price target on the stock. This represents a 0.6% upside from the current price of $38.77.
IDEX (NYSE:IEX) was upgraded by analysts at Stifel Nicolaus from a âholdâ rating to a âbuyâ rating. They now have a $265.00 price target on the stock, up previously from $215.00. This represents a 18.0% upside from the current price of $224.52.
Methanex (NASDAQ:MEOH) (TSE:MX) was upgraded by analysts at UBS Group AG from a âneutralâ rating to a âbuyâ rating. They now have a $60.00 price target on the stock, up previously from $51.00. This represents a 30.3% upside from the current price of $46.03.
MeridianLink (NYSE:MLNK) was upgraded by analysts at Wolfe Research from an âunderperformâ rating to a âpeer performâ rating.The current price is $18.75.
News (NASDAQ:NWSA) was upgraded by analysts at Macquarie from a âneutralâ rating to an âoutperformâ rating.The current price is $25.90.
Omega Healthcare Investors (NYSE:OHI) was upgraded by analysts at BNP Paribas from an âunderperformâ rating to a âneutralâ rating. They now have a $30.00 price target on the stock. This represents a 0.2% upside from the current price of $29.94.
Roblox (NYSE:RBLX) was upgraded by analysts at The Goldman Sachs Group, Inc. from a âsellâ rating to a âneutralâ rating. They now have a $48.00 price target on the stock, up previously from $35.00. This represents a 6.9% upside from the current price of $44.91.
Roblox (NYSE:RBLX) was upgraded by analysts at Barclays PLC from an âunderweightâ rating to an âequal weightâ rating. They now have a $46.00 price target on the stock, up previously from $26.00. This represents a 2.4% upside from the current price of $44.91.
Spirit AeroSystems (NYSE:SPR) was upgraded by analysts at TD Cowen from a âmarket performâ rating to an âoutperformâ rating. They now have a $35.00 price target on the stock, up previously from $27.00. This represents a 21.1% upside from the current price of $28.90.
Itâs Like Youâre Trading 24 Hours A Day⊠(ad)
Hi there, itâs Tom Busby, founder of the Diversified Trading Institute and while we know that itâs not possible to trade 24 hours a day, it is possible to learn how to profit like you do! With my new guide, the âLittle Black Bookâ, you can discover how to leverage every market to help you earn more, even when the trading day is done.
American Financial Group (NYSE:AFG) was downgraded by analysts at Piper Sandler from an âoverweightâ rating to a âneutralâ rating. They now have a $129.00 price target on the stock. This represents a 7.8% upside from the current price of $119.62.
Air Products and Chemicals (NYSE:APD) was downgraded by analysts at UBS Group AG from a âbuyâ rating to a âneutralâ rating. They now have a $241.00 price target on the stock, down previously from $328.00. This represents a 10.0% upside from the current price of $219.12.
American Express (NYSE:AXP) was downgraded by analysts at Morgan Stanley from an âoverweightâ rating to an âequal weightâ rating. They now have a $222.00 price target on the stock, up previously from $212.00. This represents a 6.3% upside from the current price of $208.78.
AstraZeneca (NASDAQ:AZN) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a âholdâ rating to a âsellâ rating.The current price is $63.05.
Alibaba Group (NYSE:BABA) was downgraded by analysts at Macquarie from an âoutperformâ rating to a âneutralâ rating. They now have a $85.40 price target on the stock, down previously from $88.50. This represents a 19.9% upside from the current price of $71.23.
Cleveland-Cliffs (NYSE:CLF) was downgraded by analysts at Argus from a âbuyâ rating to a âholdâ rating.The current price is $19.21.
Equinor ASA (NYSE:EQNR) was downgraded by analysts at DZ Bank AG from a âbuyâ rating to a âholdâ rating.The current price is $26.27.
Fortinet (NASDAQ:FTNT) was downgraded by analysts at DZ Bank AG from a âholdâ rating to a âsellâ rating. They now have a $60.00 price target on the stock. This represents a 12.2% downside from the current price of $68.34.
GoPro (NASDAQ:GPRO) was downgraded by analysts at Wedbush from an âoutperformâ rating to a âneutralâ rating. They now have a $2.00 price target on the stock, down previously from $4.00. This represents a 22.2% downside from the current price of $2.57.
Hertz Global (NASDAQ:HTZ) was downgraded by analysts at Morgan Stanley from an âoverweightâ rating to an âequal weightâ rating. They now have a $10.00 price target on the stock, down previously from $15.00. This represents a 20.9% upside from the current price of $8.27.
Envista (NYSE:NVST) was downgraded by analysts at William Blair from an âoutperformâ rating to a âmarket performâ rating.The current price is $21.83.
New York Community Bancorp (NYSE:NYCB) was downgraded by analysts at DA Davidson from a âbuyâ rating to a âneutralâ rating. They now have a $5.00 price target on the stock, down previously from $8.50. This represents a 15.2% upside from the current price of $4.34.
OneMain (NYSE:OMF) was downgraded by analysts at Piper Sandler from an âoverweightâ rating to a âneutralâ rating. They now have a $49.00 price target on the stock, down previously from $55.00. This represents a 13.8% upside from the current price of $43.07.
Werner Enterprises (NASDAQ:WERN) was downgraded by analysts at Stifel Nicolaus from a âbuyâ rating to a âholdâ rating. They now have a $42.00 price target on the stock, down previously from $45.00. This represents a 2.0% upside from the current price of $41.16.
Yield10 Bioscience (NASDAQ:YTEN) was downgraded by analysts at Lake Street Capital from a âbuyâ rating to a âholdâ rating.The current price is $0.25.
ZoomInfo Technologies (NASDAQ:ZI) was downgraded by analysts at Citigroup Inc. from a âneutralâ rating to a âsellâ rating. They now have a $13.00 price target on the stock, down previously from $20.00. This represents a 14.0% downside from the current price of $15.11.
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Cantor Fitzgerald. They set an âoverweightâ rating on the stock.The current price is $23.97.
Biodexa Pharmaceuticals (NASDAQ:BDRX) is now covered by analysts at LADENBURG THALM/SH SH. They set a âbuyâ rating and a $8.00 price target on the stock. This represents a 515.9% upside from the current price of $1.30.
Cogent Biosciences (NASDAQ:COGT) is now covered by analysts at Citigroup Inc.. They set a âbuyâ rating and a $11.00 price target on the stock. This represents a 76.8% upside from the current price of $6.22.
Torrid (NYSE:CURV) is now covered by analysts at B. Riley. They set a âbuyâ rating and a $7.00 price target on the stock. This represents a 40.6% upside from the current price of $4.98.
Cedar Fair (NYSE:FUN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an âoutperformâ rating and a $49.00 price target on the stock. This represents a 18.4% upside from the current price of $41.38.
Nextracker (NASDAQ:NXT) is now covered by analysts at Guggenheim. They set a âbuyâ rating and a $73.00 price target on the stock. This represents a 28.9% upside from the current price of $56.65.
PNM Resources (NYSE:PNM) is now covered by analysts at Barclays PLC. They set an âoverweightâ rating and a $40.00 price target on the stock. This represents a 8.5% upside from the current price of $36.85.
Bio-Techne (NASDAQ:TECH) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $80.00 price target on the stock. This represents a 18.2% upside from the current price of $67.70.
Tempest Therapeutics (NASDAQ:TPST) is now covered by analysts at Jefferies Financial Group Inc.. They set a âbuyâ rating and a $15.00 price target on the stock. This represents a 244.0% upside from the current price of $4.36.
Sign up for MarketBeat All Access to gain access to MarketBeatâs full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeatâs trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See whatâs happening in the market right now with MarketBeatâs real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeatâs free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (thatâs you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
